0001708138-20-000105.txt : 20200923 0001708138-20-000105.hdr.sgml : 20200923 20200923160051 ACCESSION NUMBER: 0001708138-20-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200921 FILED AS OF DATE: 20200923 DATE AS OF CHANGE: 20200923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201192118 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-09-21 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-09-21 4 M 0 3784 371.4 A 9427 D Common Stock 2020-09-21 4 M 0 4960 380.95 A 14387 D Common Stock 2020-09-21 4 M 0 7830 376.69 A 22217 D Common Stock 2020-09-21 4 S 0 300 543.19 D 21917 D Common Stock 2020-09-21 4 S 0 700 544.96 D 21217 D Common Stock 2020-09-21 4 S 0 800 546.01 D 20417 D Common Stock 2020-09-21 4 S 0 1356 547.28 D 19061 D Common Stock 2020-09-21 4 S 0 3654 548.13 D 15407 D Common Stock 2020-09-21 4 S 0 2600 549.07 D 12807 D Common Stock 2020-09-21 4 S 0 1600 550.11 D 11207 D Common Stock 2020-09-21 4 S 0 1501 551.09 D 9706 D Common Stock 2020-09-21 4 S 0 513 552.01 D 9193 D Common Stock 2020-09-21 4 S 0 1101 553.17 D 8092 D Common Stock 2020-09-21 4 S 0 899 554.82 D 7193 D Common Stock 2020-09-21 4 S 0 1530 555.74 D 5663 D Common Stock 2020-09-22 4 S 0 20 552.36 D 5643 D Non-Qualified Stock Option (right to buy) 371.4 2020-09-21 4 M 0 3784 0.0 D 2029-01-02 Common Stock 3784 0 D Non-Qualified Stock Option (right to buy) 376.69 2020-09-21 4 M 0 7830 0.0 D 2027-01-03 Common Stock 7830 0 D Non-Qualified Stock Option (right to buy) 380.95 2020-09-21 4 M 0 4960 0.0 D 2028-01-02 Common Stock 4960 2479 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 300 shares of Company stock on September 21, 2020 at prices ranging from $542.66 to $543.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 700 shares of Company stock on September 21, 2020 at prices ranging from $544.49 to $545.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 800 shares of Company stock on September 21, 2020 at prices ranging from $545.56 to $546.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 1,356 shares of Company stock on September 21, 2020 at prices ranging from $546.57 to $547.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 3,654 shares of Company stock on September 21, 2020 at prices ranging from $547.61 to $548.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 2,600 shares of Company stock on September 21, 2020 at prices ranging from $548.62 to $549.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 1,600 shares of Company stock on September 21, 2020 at prices ranging from $549.62 to $550.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 1,501 shares of Company stock on September 21, 2020 at prices ranging from $550.64 to $551.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 513 shares of Company stock on September 21, 2020 at prices ranging from $551.69 to $552.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 21, 2020 at prices ranging from $552.69 to $553.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 899 shares of Company stock on September 21, 2020 at prices ranging from $554.32 to $555.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. Represents volume-weighted average price of sales of 1,530 shares of Company stock on September 21, 2020 at prices ranging from $555.51 to $556.04. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price. On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Joseph L. Goldstein 2020-09-23